6:01 PM
 | 
Dec 14, 2011
 |  BC Extra  |  Clinical News

FDA to update SSRI labels for use during pregnancy

FDA said it will update drug labels of selective serotonin reuptake inhibitors to reflect conflicting results regarding the risk of persistent...

Read the full 81 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >